Publication | Closed Access

Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice

InflammationAutoimmune DiseaseTh17-related InflammationMedicineImmunologyAutophagyChronic InflammationExperimental Autoimmune EncephalomyelitisAutoimmunityImmune MediatorPharmacologyOxidative Stress